Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm (Q44529239)
Jump to navigation
Jump to search
scientific article published in August 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm |
scientific article published in August 2003 |
Statements
1 reference
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm (English)
1 reference
Harold J Burstein
1 reference
Eric P Winer
1 reference
Rosemary Lambert-Falls
1 reference
Craig A Bunnell
1 reference
Lyndsay N Harris
1 reference
P Kelly Marcom
1 reference
Kathleen Havlin
1 reference
Beth Overmoyer
1 reference
Robert J Friedlander
1 reference
Janet Gargiulo
1 reference
Rochelle Strenger
1 reference
Charles L Vogel
1 reference
Paula D Ryan
1 reference
Mathew J Ellis
1 reference
Raquel A Nunes
1 reference
Susana M Campos
1 reference
Michele Hallor
1 reference
Rebecca Gelman
1 reference
1 August 2003
1 reference
1 reference
Identifiers
1 reference